Cargando…

The Suppressive Role and Aberrent Promoter Methylation of BTG3 in the Progression of Hepatocellular Carcinoma

BACKGROUND: BTG3 (B-cell translocation gene 3) has been identified as a tumor suppressor and hypermethylation contributes to its down-regulation in some tumors, but its role in hepatocellular carcinoma (HCC) remain unknown. This study aimed to detect the expression and methylation status of BTG3 in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lv, Zhenbing, Zou, Huichun, Peng, Kaiwen, Wang, Jianmei, Ding, Yi, Li, Yuling, Ren, Xiaoli, Wang, Feifei, Chang, Rui, Liang, Li, Ding, Yanqing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3798399/ https://www.ncbi.nlm.nih.gov/pubmed/24147003 http://dx.doi.org/10.1371/journal.pone.0077473

Ejemplares similares

The SOX17/miR-371-5p/SOX2 axis inhibits EMT, stem cell properties and metastasis in colorectal cancer
por: Li, Yuling, et al.
Publicado: (2015)

FBX8 Acts as an Invasion and Metastasis Suppressor and Correlates with Poor Survival in Hepatocellular Carcinoma
por: Wang, Feifei, et al.
Publicado: (2013)

Ribonucleic acid-binding protein CPSF6 promotes glycolysis and suppresses apoptosis in hepatocellular carcinoma cells by inhibiting the BTG2 expression
por: Liu, Yang, et al.
Publicado: (2021)

Aberrant DNA methylation in hepatocellular carcinoma tumor suppression (Review)
por: DONG, YOUHONG, et al.
Publicado: (2014)

Emerging role of antiproliferative protein BTG1 and BTG2
por: Kim, Sang Hyeon, et al.
Publicado: (2022)

Formin-like2 regulates Rho/ROCK pathway to promote actin assembly and cell invasion of colorectal cancer
por: Zeng, Yuanfeng, et al.
Publicado: (2015)

Tumor suppressors BTG1 and BTG2: Beyond growth control
por: Yuniati, Laurensia, et al.
Publicado: (2018)

Targeted Deletion of Btg1 and Btg2 Results in Homeotic Transformation of the Axial Skeleton
por: Tijchon, Esther, et al.
Publicado: (2015)

miR-21-5p prevents doxorubicin-induced cardiomyopathy by downregulating BTG2
por: Wang, Qingwei, et al.
Publicado: (2023)

Circular RNA circ_0014717 Suppresses Hepatocellular Carcinoma Tumorigenesis Through Regulating miR-668-3p/BTG2 Axis
por: Ma, Hongxi, et al.
Publicado: (2021)

BTG2 and SerpinB5, a novel gene pair to evaluate the prognosis of lung adenocarcinoma
por: Yang, Wanting, et al.
Publicado: (2023)

Protein Methylation and Interaction with the Antiproliferative Gene, BTG2(/TIS21/Pc3)
por: Paik, Woon Ki, et al.
Publicado: (2014)

Novel Therapeutic Mechanism of Adipose-Derived Mesenchymal Stem Cells in Osteoarthritis via Upregulation of BTG2
por: Yang, Qinyan, et al.
Publicado: (2022)

The positive feedback between Snail and DAB2IP regulates EMT, invasion and metastasis in colorectal cancer
por: Wang, Jianmei, et al.
Publicado: (2015)

RNA binding protein PUM2 promotes hepatocellular carcinoma proliferation and apoptosis via binding to the 3′UTR of BTG3
por: Liu, Zhenhua, et al.
Publicado: (2022)

BTG2 suppresses renal cell carcinoma progression through N6-methyladenosine
por: Qi, Fuming, et al.
Publicado: (2022)

The suppressing effects of BTG3 expression on aggressive behaviors and phenotypes of colorectal cancer: An in vitro and vivo study
por: Zheng, Hua-Chuan, et al.
Publicado: (2017)

The function of BTG3 in colorectal cancer cells and its possible signaling pathway
por: Lv, Chi, et al.
Publicado: (2017)

An aberrant DNA methylation signature for predicting hepatocellular carcinoma
por: Zhang, Renhua, et al.
Publicado: (2020)

SRXN1 stimulates hepatocellular carcinoma tumorigenesis and metastasis through modulating ROS/p65/BTG2 signalling
por: Lv, Xiufang, et al.
Publicado: (2020)

BTG1 potentiates apoptosis and suppresses proliferation in renal cell carcinoma by interacting with PRMT1
por: LIU, CHUNHUI, et al.
Publicado: (2015)

Crystal structures of human BTG2 and mouse TIS21 involved in suppression of CAF1 deadenylase activity
por: Yang, Xiuna, et al.
Publicado: (2008)

TINCR inhibits the proliferation and invasion of laryngeal squamous cell carcinoma by regulating miR-210/BTG2
por: He, Guoqing, et al.
Publicado: (2021)

PRMT5 promotes cell proliferation by inhibiting BTG2 expression via the ERK signaling pathway in hepatocellular carcinoma
por: Jiang, Hai, et al.
Publicado: (2018)

BTG Interacts with Retinoblastoma to Control Cell Fate in Dictyostelium
por: Conte, Daniele, et al.
Publicado: (2010)

Bcl-2 associated athanogene 4 promotes proliferation, migration and invasion of gastric cancer cells
por: Yi, Lizhi, et al.
Publicado: (2017)

Elucidating the Landscape of Aberrant DNA Methylation in Hepatocellular Carcinoma
por: Song, Min-Ae, et al.
Publicado: (2013)

Aberrantly DNA Methylated-Differentially Expressed Genes and Pathways in Hepatocellular Carcinoma
por: Cai, Changzhou, et al.
Publicado: (2019)

The roles of BTG1 mRNA expression in cancers: A bioinformatics analysis
por: Zheng, Hua-chuan, et al.
Publicado: (2022)

BTG2 as a tumor target for the treatment of luminal A breast cancer
por: Wang, Runzhi, et al.
Publicado: (2022)

MiR-21 Protected Cardiomyocytes against Doxorubicin-Induced Apoptosis by Targeting BTG2
por: Tong, Zhongyi, et al.
Publicado: (2015)

The miR-146b-5p promotes Ewing’s sarcoma cells progression via suppressing the expression of BTG2
por: Qu, Lizhen, et al.
Publicado: (2021)

Btg2 Promotes Focal Segmental Glomerulosclerosis via Smad3‐Dependent Podocyte‐Mesenchymal Transition
por: Dan Hu, Qiong‐, et al.
Publicado: (2023)

m6A-Induced LncRNA MEG3 Suppresses the Proliferation, Migration and Invasion of Hepatocellular Carcinoma Cell Through miR-544b/BTG2 Signaling
por: Wu, Jian, et al.
Publicado: (2021)

Clinical significance of aberrant DEUP1 promoter methylation in hepatocellular carcinoma
por: Yu, Qiwen, et al.
Publicado: (2019)

Down-regulation of BTG1 by miR-454-3p enhances cellular radiosensitivity in renal carcinoma cells
por: Wu, Xin, et al.
Publicado: (2014)

BTG1 Expression Correlates with the Pathogenesis and Progression of Ovarian Carcinomas
por: Zhao, Yang, et al.
Publicado: (2013)

MiR-371a-5p Positively Associates with Hepatocellular Carcinoma Malignancy but Sensitizes Cancer Cells to Oxaliplatin by Suppressing BECN1-Dependent Autophagy
por: Lv, Zhenbing, et al.
Publicado: (2022)

BTG1 inhibits malignancy as a novel prognosis signature in endometrial carcinoma
por: Li, Yibing, et al.
Publicado: (2020)

Bioinformatics analysis of aberrantly methylated-differentially expressed genes and pathways in hepatocellular carcinoma
por: Sang, Liang, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_hbsq4s1gdmjvi9obl0e2r8pid3